Estrogen: Balanced estrogen helps regulate appetite, blood sugar, and fat distribution
Medicare Part D excludes agents used for weight loss by statute, though CMS launched the Medicare GLP-1 Bridge demonstration running July 1, 2026 through December 31, 2027, offering eligible beneficiaries certain GLP-1 drugs at a $50 copay outside the standard benefit
It hasn't been approved anywhere yet
Sermorelin stimulates endogenous growth hormone secretion, which drives lipolysis and protein synthesis, while semaglutide acts as a GLP-1 receptor agonist to slow gastric emptying and suppress appetite
An Innovative Solution To An Old Problem Dihexa is a chemical compound that can be taken orally, in capsule form, or applied as a transdermal cream
Our clinic brings medical weight loss and hormone therapy together under one roof, giving residents across Indianapoliss northeast corridor a coordinated, clinically grounded approach to better health without the need to navigate multiple providers